Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Primary Osteoarthritis of the Knee Joint With Autologous Mesenchymal Stem Cells

NCT02544802 is registered in ClinicalTrials.gov with Steminent Biotherapeutics Inc. as lead sponsor.

NCT NCT02544802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02544802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Primary Osteoarthritis of the Knee Joint With Autologous Mesenchymal Stem Cells
Lead sponsor
Steminent Biotherapeutics Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2015
Completion date
January 31, 2019
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis knee